{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T16:34:32Z","timestamp":1792427672833,"version":"4.5.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,2]],"date-time":"2025-01-02T00:00:00Z","timestamp":1735776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,1,2]],"date-time":"2025-01-02T00:00:00Z","timestamp":1735776000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Immun Ageing"],"DOI":"10.1186\/s12979-024-00495-4","type":"journal-article","created":{"date-parts":[[2025,1,2]],"date-time":"2025-01-02T04:33:16Z","timestamp":1735792396000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["High SARS-CoV-2 antibody levels after three consecutive BNT162b2 booster vaccine doses in nursing home residents"],"prefix":"10.1186","volume":"22","author":[{"given":"Marloes I","family":"Hofstee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna","family":"Kaczorowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abigail","family":"Postema","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erna","family":"Zomer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maren","family":"van Waalwijk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gustaaf","family":"Jonathans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lia GH","family":"de Rond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaby","family":"Smits","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lotus L","family":"van den Hoogen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerco","family":"den Hartog","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Marie","family":"Buisman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,2]]},"reference":[{"key":"495_CR1","unstructured":"Centers for Medicare & Medicaid Services. COVID-19 nursing home data. 2022. (accessed 11-04-2023)."},{"key":"495_CR2","doi-asserted-by":"publisher","unstructured":"Aiello A, Farzaneh F, Candore G, Caruso C, Davinelli S, Gambino CM, Ligotti ME, Zareian N, Accardi G. Immunosenescence and its Hallmarks: how to oppose aging strategically? A review of potential options for therapeutic intervention. Front Immunol. 2019;10. https:\/\/doi.org\/10.3389\/fimmu.2019.02247.","DOI":"10.3389\/fimmu.2019.02247"},{"key":"495_CR3","doi-asserted-by":"publisher","unstructured":"Weinberger B, Haks MC, de Paus RA, Ottenhoff THM, Bauer T, Grubeck-Loebenstein B. Impaired immune response to primary but not to booster vaccination against hepatitis B in older adults. Front Immunol. 2018;9(5). https:\/\/doi.org\/10.3389\/fimmu.2018.01035.","DOI":"10.3389\/fimmu.2018.01035"},{"issue":"1","key":"495_CR4","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1038\/s41467-022-28527-x","volume":"13","author":"H Ward","year":"2022","unstructured":"Ward H, Whitaker M, Flower B, Tang SN, Atchison C, Darzi A, Donnelly CA, Cann A, Diggle PJ, Ashby D, et al. Population antibody responses following COVID-19 vaccination in 212,102 individuals. Nat Commun. 2022;13(1):907. https:\/\/doi.org\/10.1038\/s41467-022-28527-x.","journal-title":"Nat Commun"},{"key":"495_CR5","unstructured":"Statistics Netherlands. 1,468 COVID-19 deaths in Q3 2022. 2023. (accessed 11-04-2023)."},{"issue":"20","key":"495_CR6","doi-asserted-by":"publisher","first-page":"2043","DOI":"10.1001\/jama.2021.19499","volume":"326","author":"MW Tenforde","year":"2021","unstructured":"Tenforde MW, Self WH, Adams K, Gaglani M, Ginde AA, McNeal T, Ghamande S, Douin DJ, Talbot HK, Casey JD, et al. Association between mRNA vaccination and COVID-19 hospitalization and Disease Severity. JAMA. 2021;326(20):2043\u201354. https:\/\/doi.org\/10.1001\/jama.2021.19499.","journal-title":"JAMA"},{"issue":"9","key":"495_CR7","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1038\/s41564-021-00947-3","volume":"6","author":"J Wei","year":"2021","unstructured":"Wei J, Stoesser N, Matthews PC, Ayoubkhani D, Studley R, Bell I, Bell JI, Newton JN, Farrar J, Diamond I, et al. Antibody responses to SARS-CoV-2 vaccines in 45,965 adults from the general population of the United Kingdom. Nat Microbiol. 2021;6(9):1140\u20139. https:\/\/doi.org\/10.1038\/s41564-021-00947-3.","journal-title":"Nat Microbiol"},{"key":"495_CR8","doi-asserted-by":"publisher","first-page":"101576","DOI":"10.1016\/j.eclinm.2022.101576","volume":"51","author":"T Bruel","year":"2022","unstructured":"Bruel T, Pinaud L, Tondeur L, Planas D, Staropoli I, Porrot F, Guivel-Benhassine F, Attia M, Pelleau S, Woudenberg T, et al. Neutralising antibody responses to SARS-CoV-2 omicron among elderly nursing home residents following a booster dose of BNT162b2 vaccine: a community-based, prospective, longitudinal cohort study. eClinicalMedicine. 2022;51:101576. https:\/\/doi.org\/10.1016\/j.eclinm.2022.101576.","journal-title":"eClinicalMedicine"},{"key":"495_CR9","doi-asserted-by":"publisher","unstructured":"Canaday DH, Oyebanji OA, White E, Keresztesy D, Payne M, Wilk D, Carias L, Aung H, St. Denis K, Sheehan ML et al. COVID-19 vaccine booster dose needed to achieve Omicron-specific neutralisation in nursing home residents. eBioMedicine.2022;80: 104066. https:\/\/doi.org\/10.1016\/j.ebiom.2022.104066","DOI":"10.1016\/j.ebiom.2022.104066"},{"issue":"9","key":"495_CR10","doi-asserted-by":"publisher","first-page":"2552","DOI":"10.1111\/jgs.17837","volume":"70","author":"H Jeulin","year":"2022","unstructured":"Jeulin H, Labat C, Duarte K, Toupance S, Nadin G, Craus D, Georgiopoulos I, Gantois I, Goehringer F, Benetos A. Anti-spike IgG antibody kinetics following the second and third doses of BNT162b2 vaccine in nursing home residents. J Am Geriatr Soc. 2022;70(9):2552\u201360. https:\/\/doi.org\/10.1111\/jgs.17837.","journal-title":"J Am Geriatr Soc"},{"key":"495_CR11","doi-asserted-by":"publisher","first-page":"100646","DOI":"10.1016\/j.lanepe.2023.100646","volume":"30","author":"L Vikstr\u00f6m","year":"2023","unstructured":"Vikstr\u00f6m L, Fj\u00e4llstr\u00f6m P, Gwon YD, Sheward DJ, Wigren-Bystr\u00f6m J, Evander M, Bladh O, Widerstr\u00f6m M, Molnar C, Rasmussen G, et al. Vaccine-induced correlate of protection against fatal COVID-19 in older and frail adults during waves of neutralization-resistant variants of concern: an observational study. Lancet Reg Health Eur. 2023;30:100646. https:\/\/doi.org\/10.1016\/j.lanepe.2023.100646.","journal-title":"Lancet Reg Health Eur"},{"issue":"4","key":"495_CR12","doi-asserted-by":"publisher","first-page":"100","DOI":"10.15585\/mmwr.mm7204a4","volume":"72","author":"DH Canaday","year":"2023","unstructured":"Canaday DH, Oyebanji OA, White EM, Bosch J, Nugent C, Vishnepolskiy I, Abul Y, Didion EM, Paxitzis A, Sundheimer N, et al. SARS-CoV-2 antibody responses to the ancestral SARS-CoV-2 strain and omicron BA.1 and BA.4\/BA.5 variants in nursing home residents after receipt of Bivalent COVID-19 vaccine - Ohio and Rhode Island, September-November 2022. MMWR Morb Mortal Wkly Rep. 2023;72(4):100\u20136. https:\/\/doi.org\/10.15585\/mmwr.mm7204a4.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"10","key":"495_CR13","doi-asserted-by":"publisher","first-page":"e29170","DOI":"10.1002\/jmv.29170","volume":"95","author":"JA Breznik","year":"2023","unstructured":"Breznik JA, Rahim A, Bhakta H, Clare R, Zhang A, Ang J, Stacey HD, Liu LM, Kennedy A, Bilaver L, et al. Early humoral and cellular responses after bivalent SARS-CoV-2 mRNA-1273.214 vaccination in long-term care and retirement home residents in Ontario, Canada: an observational cohort study. J Med Virol. 2023;95(10):e29170. https:\/\/doi.org\/10.1002\/jmv.29170.","journal-title":"J Med Virol"},{"key":"495_CR14","doi-asserted-by":"publisher","DOI":"10.1007\/s11357-024-01215-y","author":"OA Oyebanji","year":"2024","unstructured":"Oyebanji OA, Sundheimer N, Ragavapuram V, Wilson BM, Abul Y, Gravenstein S, Bosch J, King CL, Canaday DH. Avidity maturation of humoral response following primary and booster doses of BNT162b2 mRNA vaccine among nursing home residents and healthcare workers. Geroscience. 2024. https:\/\/doi.org\/10.1007\/s11357-024-01215-y.","journal-title":"Geroscience"},{"issue":"12","key":"495_CR15","doi-asserted-by":"publisher","first-page":"3947","DOI":"10.1111\/jgs.18557","volume":"71","author":"OA Oyebanji","year":"2023","unstructured":"Oyebanji OA, Abul Y, Wilson BM, Bosch J, Didion EM, Paxitzis AN, Sundheimer N, Ragavapuram V, Wilk D, Keresztesy D, et al. Neutralization and binding antibody response to second bivalent COVID-19 vaccination in nursing home residents. J Am Geriatr Soc. 2023;71(12):3947\u201350. https:\/\/doi.org\/10.1111\/jgs.18557.","journal-title":"J Am Geriatr Soc"},{"key":"495_CR16","doi-asserted-by":"publisher","first-page":"105180","DOI":"10.1016\/j.ebiom.2024.105180","volume":"105","author":"S Gravenstein","year":"2024","unstructured":"Gravenstein S, DeVone F, Oyebanji OA, Abul Y, Cao Y, Chan PA, Halladay CW, Rudolph JL, Nugent C, Bosch J, et al. Durability of immunity and clinical protection in nursing home residents following bivalent SARS-CoV-2 vaccination. EBioMedicine. 2024;105:105180. https:\/\/doi.org\/10.1016\/j.ebiom.2024.105180.","journal-title":"EBioMedicine"},{"issue":"6","key":"495_CR17","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1093\/ije\/dym292","volume":"37","author":"WMM Verschuren","year":"2008","unstructured":"Verschuren WMM, Blokstra A, Picavet HSJ, Smit HA. Cohort Profile: the Doetinchem Cohort Study. Int J Epidemiol. 2008;37(6):1236\u201341. https:\/\/doi.org\/10.1093\/ije\/dym292.","journal-title":"Int J Epidemiol"},{"key":"495_CR18","doi-asserted-by":"publisher","unstructured":"Van den Hoogen LL, Boer M, Postema A, de Rond L, de Zeeuw-Brouwer ML, Pronk I, Wijmenga-Monsuur AJ, Bijvank E, Kruiper C, Beckers L, et al. Reduced antibody Acquisition with increasing Age following vaccination with BNT162b2: results from two longitudinal cohort studies in the Netherlands. Vaccines. 2022;10(9). https:\/\/doi.org\/10.3390\/vaccines10091480.","DOI":"10.3390\/vaccines10091480"},{"issue":"9","key":"495_CR19","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1093\/infdis\/jiaa479","volume":"222","author":"G Den Hartog","year":"2020","unstructured":"Den Hartog G, Schepp RM, Kuijer M, GeurtsvanKessel C, van Beek J, Rots N, Koopmans MPG, van der Klis FRM, van Binnendijk RS. SARS-CoV-2-Specific antibody detection for Seroepidemiology: a multiplex analysis Approach Accounting for Accurate Seroprevalence. J Infect Dis. 2020;222(9):1452\u201361. https:\/\/doi.org\/10.1093\/infdis\/jiaa479.","journal-title":"J Infect Dis"},{"issue":"12","key":"495_CR20","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.7326\/m22-2089","volume":"175","author":"GVT Roozen","year":"2022","unstructured":"Roozen GVT, Prins MLM, van Binnendijk R, den Hartog G, Kuiper VP, Prins C, Janse JJ, Kruithof AC, Feltkamp MCW, Kuijer M, et al. Safety and Immunogenicity of Intradermal Fractional Dose Administration of the mRNA-1273 vaccine: a proof-of-Concept Study. Ann Intern Med. 2022;175(12):1771\u20134. https:\/\/doi.org\/10.7326\/m22-2089.","journal-title":"Ann Intern Med"},{"issue":"1","key":"495_CR21","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s12979-023-00382-4","volume":"20","author":"Y Kuijpers","year":"2023","unstructured":"Kuijpers Y, Picavet HSJ, de Rond L, de Zeeuw-Brouwer ML, Rutkens R, Gijsbers E, Slits I, Engelfriet P, Buisman AM, Verschuren WM. M. potential determinants of antibody responses after vaccination against SARS-CoV-2 in older persons: the Doetinchem Cohort Study. Immun Ageing. 2023;20(1):57. https:\/\/doi.org\/10.1186\/s12979-023-00382-4.","journal-title":"Immun Ageing"},{"issue":"12","key":"495_CR22","doi-asserted-by":"publisher","first-page":"e2245417","DOI":"10.1001\/jamanetworkopen.2022.45417","volume":"5","author":"KW McConeghy","year":"2022","unstructured":"McConeghy KW, Bardenheier B, Huang AW, White EM, Feifer RA, Blackman C, Santostefano CM, Lee Y, DeVone F, Halladay CW, et al. Infections, hospitalizations, and deaths among US nursing home residents with vs without a SARS-CoV-2 Vaccine Booster. JAMA Netw Open. 2022;5(12):e2245417. https:\/\/doi.org\/10.1001\/jamanetworkopen.2022.45417.","journal-title":"JAMA Netw Open"},{"issue":"8","key":"495_CR23","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1001\/jamainternmed.2022.2658","volume":"182","author":"K Muhsen","year":"2022","unstructured":"Muhsen K, Maimon N, Mizrahi AY, Boltyansky B, Bodenheimer O, Diamant ZH, Gaon L, Cohen D, Dagan R. Association of receipt of the fourth BNT162b2 dose with Omicron infection and COVID-19 hospitalizations among residents of Long-Term Care facilities. JAMA Intern Med. 2022;182(8):859\u201367. https:\/\/doi.org\/10.1001\/jamainternmed.2022.2658.","journal-title":"JAMA Intern Med"},{"issue":"10","key":"495_CR24","doi-asserted-by":"publisher","first-page":"1856","DOI":"10.1016\/j.immuni.2022.07.020","volume":"55","author":"JMJ Tas","year":"2022","unstructured":"Tas JMJ, Koo JH, Lin YC, Xie Z, Steichen JM, Jackson AM, Hauser BM, Wang X, Cottrell CA, Torres JL, et al. Antibodies from primary humoral responses modulate the recruitment of naive B cells during secondary responses. Immunity. 2022;55(10):1856\u2013e18711856. https:\/\/doi.org\/10.1016\/j.immuni.2022.07.020.","journal-title":"Immunity"},{"key":"495_CR25","doi-asserted-by":"publisher","unstructured":"Chen S, Guan F, Candotti F, Benlagha K, Camara NOS, Herrada AA, James LK, Lei J, Miller H, Kubo M, et al. The role of B cells in COVID-19 infection and vaccination. Front Immunol. 2022;13. https:\/\/doi.org\/10.3389\/fimmu.2022.988536.","DOI":"10.3389\/fimmu.2022.988536"},{"issue":"11","key":"495_CR26","doi-asserted-by":"publisher","first-page":"101258","DOI":"10.1016\/j.xcrm.2023.101258","volume":"4","author":"Q Wang","year":"2023","unstructured":"Wang Q, Guo Y, Tam AR, Valdez R, Gordon A, Liu L, Ho DD. Deep immunological imprinting due to the ancestral spike in the current bivalent COVID-19 vaccine. Cell Rep Med. 2023;4(11):101258. https:\/\/doi.org\/10.1016\/j.xcrm.2023.101258.","journal-title":"Cell Rep Med"},{"issue":"1","key":"495_CR27","doi-asserted-by":"publisher","first-page":"8426","DOI":"10.1038\/s41598-024-58811-3","volume":"14","author":"CS Korosec","year":"2024","unstructured":"Korosec CS, Dick DW, Moyles IR, Watmough J. SARS-CoV-2 booster vaccine dose significantly extends humoral immune response half-life beyond the primary series. Sci Rep. 2024;14(1):8426. https:\/\/doi.org\/10.1038\/s41598-024-58811-3.","journal-title":"Sci Rep"},{"issue":"76","key":"495_CR28","doi-asserted-by":"publisher","first-page":"eabm8389","DOI":"10.1126\/sciimmunol.abm8389","volume":"7","author":"MJ Robinson","year":"2022","unstructured":"Robinson MJ, Dowling MR, Pitt C, O\u2019Donnell K, Webster RH, Hill DL, Ding Z, Dvorscek AR, Brodie EJ, Hodgkin PD, et al. Long-lived plasma cells accumulate in the bone marrow at a constant rate from early in an immune response. Sci Immunol. 2022;7(76):eabm8389. https:\/\/doi.org\/10.1126\/sciimmunol.abm8389.","journal-title":"Sci Immunol"},{"issue":"5","key":"495_CR29","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1007\/s11739-023-03283-y","volume":"18","author":"C Trevisan","year":"2023","unstructured":"Trevisan C, Raparelli V, Malara A, Abbatecola AM, Noale M, Palmieri A, Fedele G, Di Lonardo A, Leone P, Schiavoni I, Stefanelli P, Volpato S, Antonelli Incalzi R, Onder G. GeroCovid Vax working group sex differences in the efficacy and safety of SARS-CoV-2 vaccination in residents of long-term care facilities: insights from the GeroCovid Vax study. Intern Emerg Med. 2023;18(5):1337\u201347. https:\/\/doi.org\/10.1007\/s11739-023-03283-y.","journal-title":"Intern Emerg Med"},{"issue":"7923","key":"495_CR30","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1038\/s41586-022-04980-y","volume":"608","author":"Y Cao","year":"2022","unstructured":"Cao Y, Yisimayi A, Jian F, Song W, Xiao T, Wang L, Du S, Wang J, Li Q, Chen X, et al. BA.2.12.1, BA.4 and BA.5 escape antibodies elicited by Omicron infection. Nature. 2022;608(7923):593\u2013602. https:\/\/doi.org\/10.1038\/s41586-022-04980-y.","journal-title":"Nature"},{"issue":"1","key":"495_CR31","doi-asserted-by":"publisher","first-page":"2254","DOI":"10.1038\/s41467-024-46490-7","volume":"15","author":"D Planas","year":"2024","unstructured":"Planas D, Staropoli I, Michel V, Lemoine F, Donati F, Prot M, Porrot F, Guivel-Benhassine F, Jeyarajah B, Brisebarre A, et al. Distinct evolution of SARS-CoV-2 Omicron XBB and BA.2.86\/JN.1 lineages combining increased fitness and antibody evasion. Nat Commun. 2024;15(1):2254. https:\/\/doi.org\/10.1038\/s41467-024-46490-7.","journal-title":"Nat Commun"},{"key":"495_CR32","doi-asserted-by":"publisher","unstructured":"Shah M, Woo HG. Omicron: a heavily mutated SARS-CoV-2 variant exhibits stronger binding to ACE2 and potently escapes approved COVID-19 therapeutic antibodies. Front Immunol. 2022;12. https:\/\/doi.org\/10.3389\/fimmu.2021.830527. Original Research.","DOI":"10.3389\/fimmu.2021.830527"}],"container-title":["Immunity & Ageing"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12979-024-00495-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12979-024-00495-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12979-024-00495-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,2]],"date-time":"2025-01-02T16:26:19Z","timestamp":1735835179000},"score":1,"resource":{"primary":{"URL":"https:\/\/immunityageing.biomedcentral.com\/articles\/10.1186\/s12979-024-00495-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,2]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["495"],"URL":"https:\/\/doi.org\/10.1186\/s12979-024-00495-4","relation":{},"ISSN":["1742-4933"],"issn-type":[{"value":"1742-4933","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,2]]},"assertion":[{"value":"15 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted according to the principles of the World Medical Association Declaration of Helsinki and its amendments since 1964, and in accordance with the Medical Research Involving Human Subject Act (WMO). The study protocols were approved by the Medical Ethics Committee of the University Medical Center (METC) Utrecht, NedMed, Utrecht (METC number: 21\/056, study number: NL76551.041.21, EudraCT 2021-001976-40. All participants signed the informed consent to participate in the study for finger prick blood sampling at all study timepoints (NL76551.041.21, EudraCT 2021-001976-40).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1"}}